Advertisement

Contributing writer

Dionise Guerra-Carrillo

Latest Content

EU Ambassador
Politics

EU Envoy to Washington Says She Expects ‘Good Relations’ With Marco Rubio

Jovita Neliupšienė, the European Union’s ambassador to the U.S., said she believes Brussels will have “good relations” with Sen. Marco Rubio (R-Fla.), President-elect Donald Trump’s pick to serve as his Secretary of State.

Larry Summers at the IOP
Politics

Former Harvard President, Treasury Secretary Summers Warns of Inflation Under Trump

Former U.S. Secretary of the Treasury Lawrence H. Summers said U.S. President-elect Donald Trump’s proposed economic policies will increase inflation at a Harvard Institute of Politics forum on Thursday.

HBS Naturalization Ceremony
Harvard Business School

Harvard Business School Welcomes 175 New U.S. Citizens at Naturalization Ceremony

Harvard Business School hosted a naturalization ceremony in Klarman Hall Thursday, welcoming 175 immigrants from 46 countries as they took their oaths of U.S. citizenship.

Nancy Pelosi Speaks at First Parish Church
Politics

Nancy Pelosi Defends Biden’s Policy Toward Gaza at Book Event Interrupted by Protests

Former House Speaker Nancy Pelosi (D-Calif.) touted the Biden administration’s support for humanitarian assistance in Gaza after pro-Palestine protesters disrupted her book talk at the First Parish Church on Wednesday.

SEC
Research

Cerebellum Only Necessary for Some Muscle Memory, Harvard Researchers Find

In an August study, researchers at the Harvard School of Engineering and Applied Sciences discovered a new distinction between long and short-term motor memories — a class of memories developed through repeated physical movements.

Dana-Farber Cancer Institute
Research

Harvard’s Wyss Institute Gives Startup License to Use Newly-Developed Biomaterials

Attivare Therapeutics, a startup founded by researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering, received a license from the Wyss Institute to use biomaterials developed at Harvard to create treatments for tumors that do not respond to existing immunotherapies.

Advertisement